RELENZA

Google image searchProduct monograph

Active ingredient

zanamivir, 5 MG/ACT

DIN: 02240863

Dosage form(s): POWDER

Route(s) of administration: INHALATION, ORAL

Schedule: Prescription

Company: GLAXOSMITHKLINE INC

Date: 13-NOV-2003

ATC:

• J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
• J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
• J05AH — Neuraminidase inhibitors (ATC, ATC/DDD)
• J05AH01 — ZANAMIVIR (ATC/DDD)

Reference brand drug: Relenza

External Links for Relenza

Search on Google

• Relenza side effects
• Relenza dosage
• zanamivir side effects
• zanamivir dosage

Glaxosmithkline Inc

Go to GlaxoSmithKline website to see drug product details. Sometimes you can find relenza photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.